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Abstract
Purpose of review Nosocomial pneumonia caused by multidrug-resistant  pathogens is increasing in the ICU, and
these infections are negatively associated with patient outcomes. Optimization of antibiotic  dosing has been
suggested as a key intervention to improve clinical outcomes in patients with nosocomial pneumonia. This review
describes the recent pharmacokinetic/pharmacodynamic data relevant to antibiotic  dosing for nosocomial 
pneumonia caused by multidrug-resistant  pathogens. Recent findings Optimal antibiotic  treatment is challenging in
critically ill patients with nosocomial pneumonia; most dosing guidelines do not consider the altered physiology and
illness severity associated with severe lung infections. Antibiotic  dosing can be guided by plasma drug
concentrations, which do not reflect the concentrations at the site of infection. The application of aggressive dosing
regimens, in accordance to the antibiotic 's pharmacokinetic/pharmacodynamic characteristics, may be required to
ensure rapid and effective drug exposure in infected lung tissues. Summary Conventional antibiotic  dosing increases
the likelihood of therapeutic failure in critically ill patients with nosocomial pneumonia. Alternative dosing strategies,
which exploit the pharmacokinetic/ pharmacodynamic properties of an antibiotic , should be strongly considered to
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